“Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S40, https://doi.org/10.25251/skin.3.supp.40.